{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:30:04Z","timestamp":1795044604421,"version":"4.10.2"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI162943"],"award-info":[{"award-number":["R01AI162943"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68681-0","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:23:46Z","timestamp":1768839826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differential membrane lipid disruption by lipopeptide antibiotics, colistin and turnercyclamycins"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9972-3425","authenticated-orcid":false,"given":"Albebson L.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3204-3235","authenticated-orcid":false,"given":"Bailey W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo G.","family":"Haygood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4200-6051","authenticated-orcid":false,"given":"Louis R.","family":"Barrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-694X","authenticated-orcid":false,"given":"Eric W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"68681_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050.  Lancet 404, 1199\u20131226 (2024).","journal-title":"Lancet"},{"key":"68681_CR2","unstructured":"WHO, https:\/\/www.who.int\/teams\/maternal-newborn-child-adolescent-health-and-ageing\/newborn-health\/newborn-infections (2025)."},{"key":"68681_CR3","doi-asserted-by":"publisher","first-page":"e1003787","DOI":"10.1371\/journal.pmed.1003787","volume":"18","author":"SCH Wen","year":"2021","unstructured":"Wen, S. C. H. et al. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: a systematic review and meta-analysis. PLoS Med. 18, e1003787 (2021).","journal-title":"PLoS Med."},{"key":"68681_CR4","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/microorganisms8111716","volume":"8","author":"FF Andrade","year":"2020","unstructured":"Andrade, F. F., Silva, D., Rodrigues, A. & Pina-Vaz, C. Colistin update on its mechanism of action and resistance, present and future challenges. Microorganisms 8, 1716 (2020).","journal-title":"Microorganisms"},{"key":"68681_CR5","doi-asserted-by":"publisher","unstructured":"Trimble, M. J., Mlyn\u00e1r\u010dik, P., Kol\u00e1\u0159, M. & Hancock, R. E. Polymyxin: alternative mechanisms of action and resistance. Cold Spring Harb. Perspect. Med. 6, https:\/\/doi.org\/10.1101\/cshperspect.a025288 (2016).","DOI":"10.1101\/cshperspect.a025288"},{"key":"68681_CR6","doi-asserted-by":"publisher","unstructured":"Ledger, E. V. K., Sabnis, A. & Edwards, A. M. Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort. Microbiology 168, https:\/\/doi.org\/10.1099\/mic.0.001136 (2022).","DOI":"10.1099\/mic.0.001136"},{"key":"68681_CR7","doi-asserted-by":"crossref","unstructured":"Lepak Alexander, J., Wang, W. & Andes David, R. Pharmacodynamic evaluation of MRX-8, a novel polymyxin, in the neutropenic mouse thigh and lung infection models against gram-negative pathogens. Antimicrob. Agents Chemother. 64, e01517\u2013e01520 (2020).","DOI":"10.1128\/AAC.01517-20"},{"key":"68681_CR8","first-page":"e00139","volume":"66","author":"R Duncan Leonard","year":"2022","unstructured":"Duncan Leonard, R., Wang, W. & Sader Helio, S. In vitro potency and spectrum of the novel polymyxin MRX-8 tested against clinical isolates of gram-negative bacteria. Antimicrob. Agents Chemother. 66, e00139\u201300122 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR9","doi-asserted-by":"publisher","first-page":"00739","DOI":"10.1128\/AAC.00739-21","volume":"65","author":"J Bruss","year":"2021","unstructured":"Bruss, J. et al. Single- and multiple-ascending-dose study of the safety, tolerability, and pharmacokinetics of the polymyxin derivative SPR206. Antimicrob. Agents Chemother. 65, 00739\u201300721 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR10","doi-asserted-by":"publisher","first-page":"e0042623","DOI":"10.1128\/aac.00426-23","volume":"67","author":"KA Rodvold","year":"2023","unstructured":"Rodvold, K. A., Bader, J., Bruss, J. B. & Hamed, K. Pharmacokinetics of SPR206 in plasma, pulmonary epithelial lining fluid, and alveolar macrophages following intravenous administration to healthy adult subjects. Antimicrob. Agents Chemother. 67, e0042623 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR11","doi-asserted-by":"publisher","unstructured":"Zurawski, D. V. et al. SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 61, https:\/\/doi.org\/10.1128\/aac.01239-17 (2017).","DOI":"10.1128\/aac.01239-17"},{"key":"68681_CR12","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1021\/acschembio.7b00589","volume":"12","author":"S G\u00f6tze","year":"2017","unstructured":"G\u00f6tze, S. et al. Structure, biosynthesis, and biological activity of the cyclic lipopeptide anikasin. ACS Chem. Biol. 12, 2498\u20132502 (2017).","journal-title":"ACS Chem. Biol."},{"key":"68681_CR13","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1073\/pnas.1319584111","volume":"111","author":"K Yamanaka","year":"2014","unstructured":"Yamanaka, K. et al. Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc. Natl. Acad. Sci. USA 111, 1957\u20131962 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR14","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1021\/acs.jnatprod.0c00152","volume":"83","author":"P Bekiesch","year":"2020","unstructured":"Bekiesch, P. et al. Viennamycins: lipopeptides produced by a Streptomyces sp. J. Nat. Prod. 83, 2381\u20132389 (2020).","journal-title":"J. Nat. Prod."},{"key":"68681_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.chembiol.2021.05.003","volume":"28","author":"BW Miller","year":"2021","unstructured":"Miller, B. W. et al. Shipworm symbiosis ecology-guided discovery of an antibiotic that kills colistin-resistant Acinetobacter. Cell Chem. Biol. 28, 1628\u20131637.e1624 (2021).","journal-title":"Cell Chem. Biol."},{"key":"68681_CR16","doi-asserted-by":"publisher","first-page":"e02306","DOI":"10.1128\/spectrum.02306-23","volume":"11","author":"AL Lim","year":"2023","unstructured":"Lim, A. L. et al. Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin. Microbiol. Spectr. 11, e02306\u2013e02323 (2023).","journal-title":"Microbiol. Spectr."},{"key":"68681_CR17","doi-asserted-by":"publisher","first-page":"e03099","DOI":"10.1128\/mBio.03099-21","volume":"12","author":"BW Simpson","year":"2021","unstructured":"Simpson, B. W. et al. Acinetobacter baumannii can survive with an outer membrane lacking lipooligosaccharide due to structural support from elongasome peptidoglycan synthesis. mBio 12, e03099\u201303021 (2021).","journal-title":"mBio"},{"key":"68681_CR18","doi-asserted-by":"publisher","first-page":"183395","DOI":"10.1016\/j.bbamem.2020.183395","volume":"1862","author":"HW Huang","year":"2020","unstructured":"Huang, H. W. DAPTOMYCIN, its membrane-active mechanism vs. that of other antimicrobial peptides. Biochim. Biophys. Acta Biomembr. 1862, 183395 (2020).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"68681_CR19","doi-asserted-by":"publisher","unstructured":"Benfield, A. H. & Henriques, S. T. Mode-of-action of antimicrobial peptides: membrane disruption vs. intracellular mechanisms. Front. Med. Technol. 2, https:\/\/doi.org\/10.3389\/fmedt.2020.610997 (2020).","DOI":"10.3389\/fmedt.2020.610997"},{"key":"68681_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s42003-020-01511-1","volume":"4","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. Outer-membrane-acting peptides and lipid II-targeting antibiotics cooperatively kill Gram-negative pathogens. Commun. Biol. 4, 31 (2021).","journal-title":"Commun. Biol."},{"key":"68681_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1021\/acsinfecdis.3c00673","volume":"10","author":"JC Stephani","year":"2024","unstructured":"Stephani, J. C., Gerhards, L., Khairalla, B., Solov\u2019yov, I. A. & Brand, I. How do antimicrobial peptides interact with the outer membrane of Gram-negative bacteria? Role of lipopolysaccharides in peptide binding, anchoring, and penetration. ACS Infect. Dis. 10, 763\u2013778 (2024).","journal-title":"ACS Infect. Dis."},{"key":"68681_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","volume":"1858","author":"RM Epand","year":"2016","unstructured":"Epand, R. M., Walker, C., Epand, R. F. & Magarvey, N. A. Molecular mechanisms of membrane targeting antibiotics. Biochim. Biophys. Acta Biomembr. 1858, 980\u2013987 (2016).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"68681_CR23","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1016\/j.csbj.2022.11.016","volume":"20","author":"W Zou","year":"2022","unstructured":"Zou, W. et al. Exploring the active core of a novel antimicrobial peptide, palustrin-2LTb, from the Kuatun frog, Hylarana latouchii, using a bioinformatics-directed approach. Comput. Struct. Biotechnol. J. 20, 6192\u20136205 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"68681_CR24","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1128\/AAC.42.12.3320","volume":"42","author":"A Giacometti","year":"1998","unstructured":"Giacometti, A., Cirioni, O., Greganti, G., Quarta, M. & Scalise, G. In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 42, 3320\u20133324 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR25","doi-asserted-by":"publisher","first-page":"e65836","DOI":"10.7554\/eLife.65836","volume":"10","author":"A Sabnis","year":"2021","unstructured":"Sabnis, A. et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife 10, e65836 (2021).","journal-title":"eLife"},{"key":"68681_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/BF00424873","volume":"78","author":"G Cerny","year":"1971","unstructured":"Cerny, G. & Teuber, M. Differential release of periplasmic versus cytoplasmic enzymes from Escherichia coli B by polymyxin B. Arch. Mikrobiol. 78, 166\u2013179 (1971).","journal-title":"Arch. Mikrobiol."},{"key":"68681_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/AAC.8.1.95","volume":"8","author":"PRG Schindler","year":"1975","unstructured":"Schindler, P. R. G. & Teuber, M. Action of polymyxin B on bacterial membranes: morphological changes in the cytoplasm and in the outer membrane of Salmonella typhimurium and Escherichia coli B. Antimicrob. Agents Chemother. 8, 95\u2013104 (1975).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR28","first-page":"115","volume":"9","author":"K Nakajima","year":"1966","unstructured":"Nakajima, K. & Kawamata, J. Studies on the mechanism of action of colistin. IV. Activation of \u201clatent\u201d ribonuclease in Escherichia coli by colistin. Biken J. 9, 115\u2013123 (1966).","journal-title":"Biken J."},{"key":"68681_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00592761","volume":"54","author":"M Teuber","year":"1967","unstructured":"Teuber, M. Precipitation of ribosomes from E. coli B by polymyxin B. Naturwissenschaften 54, 71 (1967).","journal-title":"Naturwissenschaften"},{"key":"68681_CR30","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/cbic.201300496","volume":"14","author":"LS McCoy","year":"2013","unstructured":"McCoy, L. S. et al. Polymyxins and analogues bind to ribosomal RNA and interfere with eukaryotic translation in vitro. Chembiochem 14, 2083\u20132086 (2013).","journal-title":"Chembiochem"},{"key":"68681_CR31","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1128\/AAC.46.3.875-878.2002","volume":"46","author":"JM Saugar","year":"2002","unstructured":"Saugar, J. M. et al. Activities of polymyxin B and cecropin A-melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii. Antimicrob. Agents Chemother. 46, 875\u2013878 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/msb4100135","volume":"3","author":"DJ Dwyer","year":"2007","unstructured":"Dwyer, D. J., Kohanski, M. A., Hayete, B. & Collins, J. J. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3, 91 (2007).","journal-title":"Mol. Syst. Biol."},{"key":"68681_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ijantimicag.2013.10.015","volume":"43","author":"RP Brochmann","year":"2014","unstructured":"Brochmann, R. P. et al. Bactericidal effect of colistin on planktonic Pseudomonas aeruginosa is independent of hydroxyl radical formation. Int. J. Antimicrob. Agents 43, 140\u2013147 (2014).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"68681_CR34","doi-asserted-by":"publisher","first-page":"e1008195","DOI":"10.1371\/journal.pgen.1008195","volume":"15","author":"J Bailey","year":"2019","unstructured":"Bailey, J. et al. Essential gene deletions producing gigantic bacteria. PLoS Genet. 15, e1008195 (2019).","journal-title":"PLoS Genet."},{"key":"68681_CR35","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/iub.530","volume":"63","author":"KT Elliott","year":"2011","unstructured":"Elliott, K. T. & Neidle, E. L. Acinetobacter baylyi ADP1: transforming the choice of model organism. IUBMB Life 63, 1075\u20131080 (2011).","journal-title":"IUBMB Life"},{"key":"68681_CR36","doi-asserted-by":"publisher","first-page":"13970","DOI":"10.1073\/pnas.1820001116","volume":"116","author":"MM Machovina","year":"2019","unstructured":"Machovina, M. M. et al. Enabling microbial syringol conversion through structure-guided protein engineering. Proc. Natl. Acad. Sci. USA 116, 13970\u201313976 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR37","doi-asserted-by":"publisher","unstructured":"Xu, F. et al. Critical role of 3\u2019-downstream region of pmrB in polymyxin resistance in Escherichia coli BL21(DE3). Microorganisms 9, https:\/\/doi.org\/10.3390\/microorganisms9030655 (2021).","DOI":"10.3390\/microorganisms9030655"},{"key":"68681_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1046\/j.1365-2672.2000.00971.x","volume":"88","author":"IM Helander","year":"2000","unstructured":"Helander, I. M. & Mattila-Sandholm, T. Fluorometric assessment of gram-negative bacterial permeabilization. J. Appl Microbiol. 88, 213\u2013219 (2000).","journal-title":"J. Appl Microbiol."},{"key":"68681_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17772-6","volume":"7","author":"C Muheim","year":"2017","unstructured":"Muheim, C. et al. Increasing the permeability of Escherichia coli using MAC13243. Sci. Rep. 7, 17629 (2017).","journal-title":"Sci. Rep."},{"key":"68681_CR40","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","volume":"7","author":"EH Mood","year":"2021","unstructured":"Mood, E. H. et al. Antibiotic potentiation in multidrug-resistant Gram-negative pathogenic bacteria by a synthetic peptidomimetic. ACS Infect. Dis. 7, 2152\u20132163 (2021).","journal-title":"ACS Infect. Dis."},{"key":"68681_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38577-9","volume":"9","author":"DAC Heesterbeek","year":"2019","unstructured":"Heesterbeek, D. A. C. et al. Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics. Sci. Rep. 9, 3074 (2019).","journal-title":"Sci. Rep."},{"key":"68681_CR42","doi-asserted-by":"publisher","unstructured":"Buttress, J. A. et al. A guide for membrane potential measurements in Gram-negative bacteria using voltage-sensitive dyes. Microbiology 168, https:\/\/doi.org\/10.1099\/mic.0.001227 (2022).","DOI":"10.1099\/mic.0.001227"},{"key":"68681_CR43","doi-asserted-by":"publisher","unstructured":"Boix-Lemonche, G., Lekka, M. & Skerlavaj, B. A rapid fluorescence-based microplate assay to investigate the interaction of membrane active antimicrobial peptides with whole Gram-positive bacteria. Antibiotics 9, https:\/\/doi.org\/10.3390\/antibiotics9020092 (2020).","DOI":"10.3390\/antibiotics9020092"},{"key":"68681_CR44","doi-asserted-by":"publisher","first-page":"12281","DOI":"10.1073\/pnas.1005485107","volume":"107","author":"H Strahl","year":"2010","unstructured":"Strahl, H. & Hamoen, L. W. Membrane potential is important for bacterial cell division. Proc. Natl. Acad. Sci. USA 107, 12281\u201312286 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR45","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1529\/biophysj.106.095711","volume":"92","author":"J Howe","year":"2007","unstructured":"Howe, J. et al. Thermodynamic analysis of the lipopolysaccharide-dependent resistance of Gram-negative bacteria against polymyxin B. Biophys. J. 92, 2796\u20132805 (2007).","journal-title":"Biophys. J."},{"key":"68681_CR46","doi-asserted-by":"publisher","first-page":"184172","DOI":"10.1016\/j.bbamem.2023.184172","volume":"1865","author":"CL Wouters","year":"2023","unstructured":"Wouters, C. L. et al. Breaking membrane barriers to neutralize E. coli and K. pneumoniae virulence with PEGylated branched polyethylenimine. Biochim. Biophys. Acta Biomembr. 1865, 184172 (2023).","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"68681_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/bj3150679","volume":"315","author":"S Srimal","year":"1996","unstructured":"Srimal, S., Surolia, N., Balasubramanian, S. & Surolia, A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem. J. 315, 679\u2013686 (1996).","journal-title":"Biochem. J."},{"key":"68681_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29459-2","volume":"13","author":"M Botte","year":"2022","unstructured":"Botte, M. et al. Cryo-EM structures of a LptDE transporter in complex with Pro-macrobodies offer insight into lipopolysaccharide translocation. Nat. Commun. 13, 1826 (2022).","journal-title":"Nat. Commun."},{"key":"68681_CR49","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1126\/science.aar1886","volume":"359","author":"DJ Sherman","year":"2018","unstructured":"Sherman, D. J. et al. Lipopolysaccharide is transported to the cell surface by a membrane-to-membrane protein bridge. Science 359, 798\u2013801 (2018).","journal-title":"Science"},{"key":"68681_CR50","doi-asserted-by":"publisher","first-page":"9417","DOI":"10.1073\/pnas.0402340101","volume":"101","author":"MP Bos","year":"2004","unstructured":"Bos, M. P., Tefsen, B., Geurtsen, J. & Tommassen, J. Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc. Natl. Acad. Sci. USA 101, 9417\u20139422 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR51","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/femsre\/fuv026","volume":"39","author":"F Putker","year":"2015","unstructured":"Putker, F., Bos, M. P. & Tommassen, J. Transport of lipopolysaccharide to the Gram-negative bacterial cell surface. FEMS Microbiol. Rev. 39, 985\u20131002 (2015).","journal-title":"FEMS Microbiol. Rev."},{"key":"68681_CR52","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1073\/pnas.0604744103","volume":"103","author":"T Wu","year":"2006","unstructured":"Wu, T. et al. Identification of a protein complex that assembles lipopolysaccharide in the outer membrane of Escherichia coli. Proc. Natl. Acad. Sci. USA 103, 11754\u201311759 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR53","doi-asserted-by":"publisher","first-page":"15536","DOI":"10.1016\/S0021-9258(17)36289-0","volume":"260","author":"MS Anderson","year":"1985","unstructured":"Anderson, M. S., Bulawa, C. E. & Raetz, C. R. The biosynthesis of gram-negative endotoxin. Formation of lipid A precursors from UDP-GlcNAc in extracts of Escherichia coli. J. Biol. Chem. 260, 15536\u201315541 (1985).","journal-title":"J. Biol. Chem."},{"key":"68681_CR54","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1073\/pnas.0705833104","volume":"104","author":"AH Williams","year":"2007","unstructured":"Williams, A. H. & Raetz, C. R. H. Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase. Proc. Natl. Acad. Sci. USA 104, 13543\u201313550 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68681_CR55","doi-asserted-by":"publisher","unstructured":"Lieberman, L. A. Outer membrane vesicles: a bacterial-derived vaccination system. Front. Microbiol. 13, https:\/\/doi.org\/10.3389\/fmicb.2022.1029146 (2022).","DOI":"10.3389\/fmicb.2022.1029146"},{"key":"68681_CR56","doi-asserted-by":"publisher","first-page":"628801","DOI":"10.3389\/fmicb.2021.628801","volume":"12","author":"SL Reimer","year":"2021","unstructured":"Reimer, S. L. et al. Comparative analysis of outer membrane vesicle isolation methods with an Escherichia coli tolA mutant reveals a hypervesiculating phenotype with outer-inner membrane vesicle content. Front. Microbiol. 12, 628801 (2021).","journal-title":"Front. Microbiol."},{"key":"68681_CR57","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1128\/JB.180.18.4872-4878.1998","volume":"180","author":"A Bernadac","year":"1998","unstructured":"Bernadac, A., Gavioli, M., Lazzaroni, J. C. & Raina, S. & Lloub\u00e8s, R. Escherichia coli tol-pal mutants form outer membrane vesicles. J. Bacteriol. 180, 4872\u20134878 (1998).","journal-title":"J. Bacteriol."},{"key":"68681_CR58","doi-asserted-by":"publisher","first-page":"701625","DOI":"10.3389\/fcimb.2021.701625","volume":"11","author":"X Li","year":"2021","unstructured":"Li, X. et al. The attenuated protective effect of outer membrane vesicles produced by a mcr-1 positive strain on colistin sensitive Escherichia coli. Front. Cell Infect. Microbiol. 11, 701625 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"68681_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0006-3002(55)90191-8","volume":"16","author":"AV Few","year":"1955","unstructured":"Few, A. V. The interaction of polymyxin E with bacterial and other lipids. Biochim. Biophys. Acta 16, 137\u2013145 (1955).","journal-title":"Biochim. Biophys. Acta"},{"key":"68681_CR60","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1248\/cpb.33.1729","volume":"33","author":"T Araki","year":"1985","unstructured":"Araki, T., Hiroguchi, J., Matsunaga, H. & Kimura, Y. Potentiating effect of lysophosphatidylcholine on antibacterial activity of polymyxin antibiotics. Chem. Pharm. Bull. 33, 1729\u20131733 (1985).","journal-title":"Chem. Pharm. Bull."},{"key":"68681_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0005-2736(75)90078-4","volume":"375","author":"M Imai","year":"1975","unstructured":"Imai, M., Inoue, K. & Nojima, S. Effect of polymyxin B on liposomal membranes derived from Escherichia coli lipids. Biochim. Biophys. Acta 375, 130\u2013137 (1975).","journal-title":"Biochim. Biophys. Acta"},{"key":"68681_CR62","doi-asserted-by":"publisher","first-page":"e00010","DOI":"10.1128\/aac.00010-23","volume":"67","author":"X Zhao","year":"2023","unstructured":"Zhao, X. et al. Elucidating the mechanism of action of the Gram-negative-pathogen-selective cyclic antimicrobial lipopeptide brevicidine. Antimicrob. Agents Chemother. 67, e00010\u2013e00023 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68681_CR63","doi-asserted-by":"publisher","unstructured":"Giordano Nicole, P., Cian Melina, B. & Dalebroux Zachary, D. Outer membrane lipid secretion and the innate immune response to Gram-negative bacteria. Infect. Immun. 88, https:\/\/doi.org\/10.1128\/iai.00920-19 (2020).","DOI":"10.1128\/iai.00920-19"},{"key":"68681_CR64","doi-asserted-by":"publisher","first-page":"e62518","DOI":"10.7554\/eLife.62518","volume":"9","author":"N Coudray","year":"2020","unstructured":"Coudray, N. et al. Structure of bacterial phospholipid transporter MlaFEDB with substrate bound. eLife 9, e62518 (2020).","journal-title":"eLife"},{"key":"68681_CR65","doi-asserted-by":"publisher","first-page":"00149","DOI":"10.1128\/msystems.00149-18","volume":"4","author":"M-L Han","year":"2019","unstructured":"Han, M.-L. et al. Comparative metabolomics and transcriptomics reveal multiple pathways associated with polymyxin killing in Pseudomonas aeruginosa. mSystems 4, 00149\u201300118 (2019). 10.1128\/msystems.","journal-title":"mSystems"},{"key":"68681_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00874-3","volume":"29","author":"MH Mahamad Maifiah","year":"2022","unstructured":"Mahamad Maifiah, M. H. et al. Integrated metabolomic and transcriptomic analyses of the synergistic effect of polymyxin\u2013rifampicin combination against Pseudomonas aeruginosa. J. Biomed. Sci. 29, 89 (2022).","journal-title":"J. Biomed. Sci."},{"key":"68681_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/antibiotics10050528","volume":"10","author":"Y Tao","year":"2021","unstructured":"Tao, Y. et al. Colistin treatment affects lipid composition of Acinetobacter baumannii. Antibiotics 10, 528 (2021).","journal-title":"Antibiotics"},{"key":"68681_CR68","doi-asserted-by":"publisher","first-page":"2000704","DOI":"10.1002\/advs.202000704","volume":"7","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. Polymyxins bind to the cell surface of unculturable Acinetobacter baumannii and cause unique dependent resistance. Adv. Sci. 7, 2000704 (2020).","journal-title":"Adv. Sci."},{"key":"68681_CR69","doi-asserted-by":"publisher","first-page":"27047","DOI":"10.1074\/jbc.274.38.27047","volume":"274","author":"TJO Wyckoff","year":"1999","unstructured":"Wyckoff, T. J. O. & Raetz, C. R. H. The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase: chemical modification and site-directed mutagenesis. J. Biol. Chem. 274, 27047\u201327055 (1999).","journal-title":"J. Biol. Chem."},{"key":"68681_CR70","doi-asserted-by":"publisher","first-page":"32896","DOI":"10.1016\/S0021-9258(20)30075-2","volume":"269","author":"S Mohan","year":"1994","unstructured":"Mohan, S., Kelly, T. M., Eveland, S. S., Raetz, C. R. & Anderson, M. S. An Escherichia coli gene (FabZ) encoding (3R)-hydroxymyristoyl acyl carrier protein dehydrase. Relation to fabA and suppression of mutations in lipid A biosynthesis. J. Biol. Chem. 269, 32896\u201332903 (1994).","journal-title":"J. Biol. Chem."},{"key":"68681_CR71","unstructured":"Zhang, Y.-M. & Rock, C. O. in (eds Ridgway, N. D. & McLeod, R. S.) Biochemistry of Lipids, Lipoproteins and Membranes, Sixth Edition, 73\u2013112 (Elsevier, 2016)."},{"key":"68681_CR72","doi-asserted-by":"publisher","unstructured":"Bertani, B. & Ruiz, N. Function and biogenesis of lipopolysaccharides. EcoSal Plus 8, https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0001-2018 (2018).","DOI":"10.1128\/ecosalplus.ESP-0001-2018"},{"key":"68681_CR73","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3389\/fmicb.2018.03285","volume":"9","author":"N Thomanek","year":"2019","unstructured":"Thomanek, N. et al. Intricate crosstalk between lipopolysaccharide, phospholipid and fatty acid metabolism in Escherichia coli modulates proteolysis of LpxC. Front. Microbiol. 9, 2018 (2019).","journal-title":"Front. Microbiol."},{"key":"68681_CR74","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1128\/JB.00131-15","volume":"197","author":"LA Gallagher","year":"2015","unstructured":"Gallagher, L. A. et al. Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii. J. Bacteriol. 197, 2027\u20132035 (2015).","journal-title":"J. Bacteriol."},{"key":"68681_CR75","unstructured":"Lewis II, J. S. et al. CLSI M100-Ed35 Performance Standards for Antimicrobial Susceptibility Testing Standards. 35th Edition, Clinical and Laboratory Standards Institute (2025)."},{"key":"68681_CR76","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. 49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"68681_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1744-3","volume":"18","author":"JP Koelmel","year":"2017","unstructured":"Koelmel, J. P. et al. LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinform. 18, 331 (2017).","journal-title":"BMC Bioinform."},{"key":"68681_CR78","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Res. 43, W251\u2013W257 (2015).","journal-title":"Nucleic Acids Res."},{"key":"68681_CR79","doi-asserted-by":"publisher","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"4","author":"M Sud","year":"2016","unstructured":"Sud, M. et al. Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 4, D463\u2013D470 (2016).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68681-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68681-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:06:41Z","timestamp":1771603601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68681-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68681"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68681-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"14 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: E.W.S., B.W.M., and M.G.H. have submitted a patent application for turnercyclamycins. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1880"}}